NO752568L - - Google Patents

Info

Publication number
NO752568L
NO752568L NO752568A NO752568A NO752568L NO 752568 L NO752568 L NO 752568L NO 752568 A NO752568 A NO 752568A NO 752568 A NO752568 A NO 752568A NO 752568 L NO752568 L NO 752568L
Authority
NO
Norway
Prior art keywords
gel
diagnostic reagent
erythrocytes
virus
reagent according
Prior art date
Application number
NO752568A
Other languages
English (en)
Norwegian (no)
Inventor
S M Russell
L W J Bishop
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of NO752568L publication Critical patent/NO752568L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO752568A 1974-07-19 1975-07-18 NO752568L (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB32050/74A GB1501395A (en) 1974-07-19 1974-07-19 Viral anti-body detection

Publications (1)

Publication Number Publication Date
NO752568L true NO752568L (enrdf_load_stackoverflow) 1976-01-20

Family

ID=10332393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752568A NO752568L (enrdf_load_stackoverflow) 1974-07-19 1975-07-18

Country Status (21)

Country Link
JP (1) JPS5135418A (enrdf_load_stackoverflow)
AT (1) AT352289B (enrdf_load_stackoverflow)
AU (1) AU500101B2 (enrdf_load_stackoverflow)
BE (1) BE831554A (enrdf_load_stackoverflow)
BR (1) BR7504584A (enrdf_load_stackoverflow)
CA (1) CA1054935A (enrdf_load_stackoverflow)
CH (1) CH621874A5 (enrdf_load_stackoverflow)
DE (1) DE2532283A1 (enrdf_load_stackoverflow)
DK (1) DK328075A (enrdf_load_stackoverflow)
ES (1) ES439520A1 (enrdf_load_stackoverflow)
FI (1) FI752081A7 (enrdf_load_stackoverflow)
FR (1) FR2278308A1 (enrdf_load_stackoverflow)
GB (1) GB1501395A (enrdf_load_stackoverflow)
IE (1) IE41633B1 (enrdf_load_stackoverflow)
IL (1) IL47736A (enrdf_load_stackoverflow)
IT (1) IT1048304B (enrdf_load_stackoverflow)
NL (1) NL7508624A (enrdf_load_stackoverflow)
NO (1) NO752568L (enrdf_load_stackoverflow)
NZ (1) NZ178160A (enrdf_load_stackoverflow)
SE (1) SE7508228L (enrdf_load_stackoverflow)
ZA (1) ZA754643B (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146852A (en) * 1979-01-31 1983-05-24 Koichi Kondo Reagent for latex agglutination

Also Published As

Publication number Publication date
DK328075A (da) 1976-01-20
IL47736A0 (en) 1975-10-15
IT1048304B (it) 1980-11-20
IE41633B1 (en) 1980-02-13
JPS5135418A (enrdf_load_stackoverflow) 1976-03-25
NL7508624A (nl) 1976-01-21
BE831554A (fr) 1976-01-19
ES439520A1 (es) 1977-04-01
FI752081A7 (enrdf_load_stackoverflow) 1976-01-20
AT352289B (de) 1979-09-10
GB1501395A (en) 1978-02-15
CH621874A5 (en) 1981-02-27
ATA558875A (de) 1979-02-15
AU8317575A (en) 1977-01-20
BR7504584A (pt) 1976-07-06
IE41633L (en) 1976-01-19
FR2278308B1 (enrdf_load_stackoverflow) 1979-03-09
SE7508228L (sv) 1976-01-20
DE2532283A1 (de) 1976-01-29
FR2278308A1 (fr) 1976-02-13
NZ178160A (en) 1978-06-20
IL47736A (en) 1978-07-31
ZA754643B (en) 1977-02-23
AU500101B2 (en) 1979-05-10
CA1054935A (en) 1979-05-22

Similar Documents

Publication Publication Date Title
US20180204137A1 (en) Stabilizing composition for immobilized biomolecules
Schaffer et al. Purification and properties of poliovirus
DK161219B (da) Proeveudstyr og fremgangsmaade til bestemmelse af streptococcus a
US4176174A (en) Viral antibody diagnostic test system
US4284725A (en) Virus titration and identification system
JPS60237365A (ja) 免疫細胞化学用顕微鏡対照スライド
RU2082417C1 (ru) Противовирусное средство, вакцина на его основе, способ ее получения, терапевтический агент и способ обнаружения компонентов рнк-вирусов
NO752568L (enrdf_load_stackoverflow)
EA013228B1 (ru) Способ получения обогащённого поликлонального антитела, высокоспецифичного к антигену поверхностного полисахарида липоарабиноманнана микобактерий, и способы его применения
EP3608672B1 (en) Crude native hapten-based indirect elisa assay kit and lyophilised controls for the confirmatory diagnosis of bovine brucellosis in blood serum and milk by animal and tank
US3777014A (en) Method and reagents for the diagnosis of viral diseases
US4296024A (en) Human immune serum globulin with high hepatitis A antibody titer
NO325631B1 (no) Fremgangsmate for bestemmelse av infeksjoner pa proteser
Hanson et al. Properties of duck hepatitis virus
Bar-Joseph et al. Booster immunization with a partially purified citrus tristeza virus (CTV) preparation after priming with recombinant CTV coat protein enhances the binding capacity of capture antibodies by ELISA
Grayston et al. Adenoviruses. I. The effect of total incubation time in HeLa cell cultures on the isolation rate
Thraenhart et al. Standardization of a rapid modified micro-neuraminidase-inhibition test (Essen-NIT) for influenza virus-neuraminidase antibody assay and comparison with the WHO method
RU2435589C2 (ru) Состав консервирующей добавки к контрольным материалам, используемым при серодиагностике сифилиса
US4092409A (en) Method for the diagnosis of viral diseases
RU2688334C1 (ru) Способ определения специфической активности антирабического иммуноглобулина на клеточной культуре с применением атомно-силовой микроскопии
Corbel et al. Soluble antigens obtained from influenza virus by treatment with non-ionic detergent
EP0030016A2 (en) Method of preserving monolayers of tissue culture cells, and tissue culture cells so preserved
SU1652338A1 (ru) Штамм культивируемых клеток почки эмбриона коровы дл культивировани вируса лейкоза крупного рогатого скота
RU2314540C2 (ru) МАСТЕР ПАНЕЛИ СЫВОРОТОК, СОДЕРЖАЩИХ И НЕ СОДЕРЖАЩИХ HBsAg, И СПОСОБ ЕЕ ПОЛУЧЕНИЯ
RU2064794C1 (ru) Средство для определения степени аттенуации вируса полиомиелита